US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 28.740
  • -0.090-0.31%
Close Nov 7 16:00 ET
3.58BMarket Cap-14157P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
199.82M
196.83M
-2.99M
Miss Est.
+81.00%
+78.29%
-1.50%
EPS
-0.31
-0.46
-0.15
Miss Est.
+73.23%
+60.68%
-46.87%
Analyst Rating
Buy

Nov 7, 2024

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 193.428M --
-- 2024/Q4 -- / 191.204M --
Nov 5, 2024 2024/Q3 196.830M / 199.824M --
Aug 1, 2024 2024/Q2 199.685M / 191.306M --
May 7, 2024 2024/Q1 172.325M / 164.259M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 193.428M--
--2024/Q4-- / 191.204M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

  • Apellis Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5 20:01

  • Apellis Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 19:07

  • Apellis Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 19:04

  • Apellis Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 1 06:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Buy

    • Buy

      72.22%

    • Hold

      27.78%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Gene Editing
    Gene Editing
    Intraday+1.61%